Oct 08, 2019 / 03:15PM GMT
Maury Raycroft - Jefferies LLC - Analyst
Okay, my name is Maury Raycroft and I am one of the biotech analysts at Jefferies. And I'd like to welcome Sandy Macrae, the CEO of Sangamo Therapeutics. Thanks for joining us today, Sandy.
Sandy Macrae - Sangamo Therapeutics, Inc. - President & CEO
It is a pleasure to be here.
Questions and Answers:
Maury Raycroft - Jefferies LLC - AnalystGreat. And so we are going to do a fireside chat. Maybe to start it off, if you can give an overview of Sangamo's pipeline for people that are new to the story, and what are important catalysts for the next 6 to 12 months.
Sandy Macrae - Sangamo Therapeutics, Inc. - President & CEO
So Sangamo is a fascinating Company. We are the genomic medicine company. We are known for our zinc fingers and our editing capabilities and editing is core of what we do. But if you can do editing, you can do a range of different things through our knowledge of genomic manipulation and AAVs and taking
Trustpilot
